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Abstract
Background: Alu repeats, which account for ~10% of the human genome, were originally considered to be junk
DNA. Recent studies, however, suggest that they may contain transcription factor binding sites and hence possibly
play a role in regulating gene expression.
Results: Here, we show that binding sites for a highly conserved member of the nuclear receptor superfamily of
ligand-dependent transcription factors, hepatocyte nuclear factor 4alpha (HNF4a, NR2A1), are highly prevalent in
Alu repeats. We employ high throughput protein binding microarrays (PBMs) to show that HNF4a binds > 66
unique sequences in Alu repeats that are present in ~1.2 million locations in the human genome. We use
chromatin immunoprecipitation (ChIP) to demonstrate that HNF4a binds Alu elements in the promoters of target
genes (ABCC3, APOA4, APOM, ATPIF1, CANX, FEMT1A, GSTM4, IL32, IP6K2, PRLR, PRODH2, SOCS2, TTR) and luciferase
assays to show that at least some of those Alu elements can modulate HNF4a-mediated transactivation in vivo
(APOM, PRODH2, TTR, APOA4). HNF4a-Alu elements are enriched in promoters of genes involved in RNA processing
and a sizeable fraction are in regions of accessible chromatin. Comparative genomics analysis suggests that there
may have been a gain in HNF4a binding sites in Alu elements during evolution and that non Alu repeats, such as
Tiggers, also contain HNF4a sites.
Conclusions: Our findings suggest that HNF4a, in addition to regulating gene expression via high affinity binding
sites, may also modulate transcription via low affinity sites in Alu repeats.
Background
As much as 50% of the ~3 billion base pairs in the
human genome may be derived from repetitive DNA
sequence [1]. While repetitive DNA is often referred to
as “junk” DNA, even when that term was originally
coined it was hypothesized that junk DNA may play an
active role in genome function [2]. The notion that
repetitive DNA may play a regulatory role and be
involved in the evolution of gene regulation was also
postulated early on, although it was not until recently
that there was evidence to support those ideas [3-5].
A major category of repetitive DNA is short inter-
spersed nuclear elements (SINEs), which are believed to
have originated from the 7SL RNA gene that is part of
the ribosome complex [6]. In the human genome, the
largest class of SINEs are Alu repeats, which at ~1.2
million copies account for ~10% of the human genome
[1]. Alu elements were first characterized as ~300
nucleotide repetitive sequences that contain an AluI
restriction site (5’-AGCT-3’) from the bacterium Arthro-
bacter luteus [7,8]. Alu elements, which are still mobile
in the human genome by virtue of the action of a LINE-
1 reverse transcriptase [9], are a relatively recent occur-
rence evolutionarily. They are found exclusively in pri-
mates, including humans, and hence are postulated to
have entered the mammalian genome ~60-65 million
years ago [10].
Alu elements have been implicated in several human
diseases including leukemia, hemophilia and breast can-
cer, suggesting that their impact on human health may
be significant [11]. There are several well characterized
examples of Alu insertions affecting splicing patterns
and hence protein function [12]. A variety of transcrip-
tion factor (TF) binding sites (TFBSs) have also been
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[13], Sp1 [14], tumor suppressor p53 [15], homeodo-
main and TATA binding proteins [16]. Nuclear recep-
tors (NR), which belong to a superfamily of ligand-
dependent TFs, have also been found to have binding
sites in Alu elements: retinoid acid receptor (RAR,
NR1B) [17], estrogen receptor (ER, NR3A) [18,19], pro-
gesterone receptor (PR, NR3C3) [20] and vitamin D
receptor (VDR, NR1I1) [21]. Alu insertions have also
been shown to alter the expression of at least six human
genes: CD8a (CD8A), keratin 18 (KRT18), parathyroid
hormone (PTH),W i l m ’s tumor 1 (WT1), receptor for Fc
fragment of IgE, high affinity I, gamma polypeptide
(FCER1G) and breast cancer 1, early onset (BRCA1)
[22]. Therefore, Alu sequences may regulate the level of
transcripts and hence proteins in the cell, as well as the
function of those proteins.
Hepatocyte nuclear factor 4 alpha, (HNF4a,N R 2 A 1 )
is a member of the NR superfamily that is highly
expressed in the liver, as well as the kidney, intestine
(large and small), pancreas and stomach [23]. HNF4a is
best known for its role in the adult liver and pancreas,
as well as in early development [24,25]; it also has an
emerging role in the gut [26-28]. The HNF4Α gene is
mutated in an inherited form of type 2 diabetes, matur-
ity onset diabetes of the young 1 (MODY1) [29], and
was recently identified as a susceptibility locus in
inflammatory bowel disease (IBD) [30]. Mutations in
HNF4a binding sites have also been directly linked to
human diseases, including hemophilia and MODY3
[31,32]. Many NRs are common drug targets [33]; the
recent identification of the endogenous ligand of
HNF4a that binds in a reversible fashion also makes
HNF4a a potential drug target [34,35].
In addition to its medical relevance, HNF4a also
appears to play a unique role in the evolution of NRs. It
is highly conserved across species, with 100% amino
acid conservation in the DNA binding domain of all
mammalian HNF4a.W h i l eH N F 4 a is most similar to
the retinoid × receptor alpha (RXRa, NR2B1), unlike
many other NRs, it does not heterodimerize with RXR.
Rather, it binds DNA in the form of direct repeats sepa-
rated by one nucleotide (DR1, AGGTCAxAGGTCA)
exclusively as a homodimer [36]. HNF4a has been
found in every animal organism examined thus far,
including sponge and coral [37], and has been postu-
lated to be the ancestor of the entire NR family [38].
Many hundreds of HNF4a target genes have been
identified by both classical promoter analysis as well as
more modern genome-wide studies [32,39-41]. During
one such genomic study, we observed a very uneven fre-
quency profile of individual HNF4a binding sequences
[42]. Specifically, we noted that a certain DNA sequence
designated H4.141 (5’-AGGCTGaAGTGCA-3’)w a s>
100-fold overrepresented compared to other HNF4a
binding sites in the human, but not the mouse, genome
(see additional file 1: Figure S1). In the current study,
we investigate the notion that these and other HNF4a
binding sequences are in Alu repeats. We use the
powerful high throughput technology of protein binding
micorarrays (PBMs) to show that HNF4a does indeed
bind numerous sequences in Alu repeats in vitro.W e
perform ChIP and luciferase assays to show that HNF4a
binds at least some Alu sequences in vivo and that
those binding events are associated with transcriptional
activation. Finally, we investigate accessibility of these
sites by correlation with DNase hypsersensitivity data
and evolutionary conservation by comparative genomic
analysis.
Results
HNF4a binds Alu repeats in vitro
Since genome-wide location analysis (i.e., ChIP-chip/seq)
often filters out or cannot distinguish the exact location
o fT Fb i n d i n ge v e n t si nh i g h l yr e p e t i t i v eD N A ,w et o o k
a combined in vitro/in silico approach to determine
whether HNF4a binds Alu elements. We generated a
custom protein binding microarray (PBM3) that con-
tained 200 unique Alu-associated sequences (Figure 1).
Since RAR was previously shown to bind DR2-like
sequences (AGGTCAxxAGGTCA) in Alu repeats [17]
and since we have previously shown that HNF4a,w h i l e
preferring DR1s, can also bind DR2s [43], we also put
on the PBM ~1470 permutations of DR1 and DR2
sequences as well as ~150 random controls and ~2000
additional sequences in the human genome predicted by
a support vector machine (SVM) algorithm to bind
HNF4a [42]. Each sequence was replicated four times
for a total of more than 15,000 spots of DNA.
We found that human HNF4a2 bound 66 out of
200 Alu-derived 13-mers in a significant fashion (> 2
SD better than random controls, p-value < 0.045 for
the lowest binder) (Figure 2A). It also bound 994 out
of 3796 non Alu-derived sequences, although eight of
those sequences were subsequently found also to be
associated with Alu repeats at a frequency of > 90%.
An exact match search of the entire human genome
(hg18) with the 1060 sequences that bound HNF4a in
the PBM (66 + 994) showed that there are a total of
1,320,513 occurrences of those HNF4a binding sites
in the genome and that the vast majority (94.9%,
1,252,918) are in repetitive elements, of which most
(95.7%, 1,198,534) are in Alu repeats (Figure 2A). This
number is much greater than that previously found
for RAR binding sites in Alu elements but that is
most likely due to the fact that strict DR1 and DR2
consensus sequences were used for the genomic
search [17].
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DR2-derived sequences bound by HNF4a were essen-
tially identical and suggested that for HNF4a the core
of CAAAG is more relevant than the AGGTCA half
sites (Figure 2B). Interestingly, the PWM of the Alu-
derived 13-mers bound by HNF4a did not contain a
prominent CAAAG core but did contain an identifiable
AGGTCA half site on the right hand side; the left hand
portion was primarily C-rich. Overall, the Alu-derived
PWM strongly resembled the non canonical HNF4a
PWM we identified in our previous PBM study [42],
although the association of the non canonical motif with
Alu elements was not investigated. A partial list of DNA
sequences significantly bound by HNF4a in the PBM
and their estimated frequencies in Alu repeats and the
human genome (hg18) is given in Table 1 (see addi-
tional file 2:T a b l eS 1for the complete list of HNF4a-
bound motifs associated with Alu repeats).
HNF4a binds Alu repeats in the promoter region of
target genes in vivo
To investigate HNF4a binding to Alu repeats in the
promoters of HNF4a target genes in vivo, we performed
a ChIP assay for HNF4a in human hepatocellular carci-
noma HepG2 cells that express HNF4a and many of its
target genes. Several criteria were used for selecting
potential Alu sequences for ChIP analysis. First, the Alu
element had to contain a probable HNF4a binding site
based on the PBM results. Second, the gene containing
the Alu element had to be down regulated > 1.4-fold by
HNF4a RNAi in HepG2 cells as determined by expres-
sion profiling [42]. Third, the Alu repeat had to be
within -5 kb to +1 kb of the transcription start site
(TSS) of the gene. Fourth, the Alu element had to be
amenable to primer design and PCR amplification, non
t r i v i a lc r i t e r i ad u et ot h er e p e t i t i v en a t u r eo ft h e
sequences. Overall, 47 sets of primers for 35 genes were
designed, of which 15 sets gave a specific signal from
the input control, indicating appropriate amplification of
the Alu sequence. Finally, of those 15 primer sets, 13
genes yielded a significant signal in the HNF4a ChIP
assay compared to the corresponding negative control
IgG (Figure 3). These results indicate that HNF4a binds
the Alu elements in the promoter regions of these target
genes in vivo.
HNF4a activates transcription from Alu elements
In order to determine whether the binding of HNF4a to
the Alu elements observed in vivo could drive transcrip-
tion, we subcloned into a luciferase reporter construct
200
Alu-derived
13-mers
An An
Terminal A-stretch Mid A-stretch
0 100 200 300
Box B Box A
PBM
~700 DR1s
~770 DR2s
~150 controls
~2,000 SVM sites
Genomic 
Analysis
4 x ~3800 sequences
HNF4D protein
Figure 1 Schematic diagram of the protein binding microarray (PBM) designed to test the ability of HNF4a to bind Alu-derived DNA
sequences. Top, schematic structure of a generic Alu element (~300 nt long) comprised of two related, but non identical monomers, the right
and left arms (adapted from [75]). Box A and B are RNA Pol III internal promoters. Relative positions of the 200 Alu-derived 13-mers incorporated
into PBM3 are also shown. Bottom, remaining DNA probes on PBM3 and workflow.
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Page 3 of 15with a minimal core promoter the PCR fragments con-
taining the Alu element with the HNF4a binding site
(HNF4a-Alu element). Three of the genes ChIP’db y
HNF4a in HepG2 cells were analyzed – APOM, TTR
and PRODH2. Transient transfection into an HNF4a-
responsive cell line (HEK 293T) showed that HNF4a2
significantly transactivates the luciferase constructs in a
dose-dependent manner (Figure 4A). While the fold
induction was not large (1.5 to 2.7-fold), it was compar-
able to two reporter constructs containing a single clas-
sical HNF4a response element (2.0- and 4.8-fold)
(Figure 4B). To determine whether an HNF4a-Alu ele-
ment could contribute to transcription of a native pro-
moter, we analyzed the APOA4 promoter construct that
contained both an HNF4a-Alu element as well as a clas-
sical HNF4a response element. The wildtype (WT) pro-
moter was transactivated well by HNF4a (4.9-fold) and
mutations in the HNF4a binding site in either the Alu
element or the classical response element reduced the
transactivation (to 3.4- and 3.2-fold, respectively) (Figure
4C). While the effect of the mutation in the HNF4a-Alu
site was not large, it was statistically signficant (p <
0.001) and comparable to the mutation in the classical
site. Taken together, these results indicate not only that
HNF4a binds Alu elements in the promoters of HNF4a
target genes in vivo, but also that this binding can con-
tribute to the overall transcriptional activity of the gene.
Frequency of HNF4a sites in Alu and non Alu repeats
In order to determine the prevalence of HNF4a binding
sites in Alu elements, a search of all the Alu repeats in
the human genome (hg18) was performed with the
~1060 (66 +994) sequences bound by HNF4a in PBM3;
the vast majority of hits were obtained with the 66 + 8
Alu-derived sequences. Approximately ~750,000 out of
~1,175,000 Alu repeats in Repeat Masker (~64%) were
found to contain at least one DNA sequence to which
HNF4a bound in PBM3; there was also a substantial
number of Alu repeats (~338,000, ~45%) that contained
more than one HNF4a binding site (Table 2). All told
there were nearly ~1.2 million HNF4a binding sites in
Alu repeats in the human genome.
Different families of Alu repeats were found to have
different frequencies of HNF4a sites (Table 3) and
w i t h i nag i v e nA l uf a m i l yt h e r ew a sar a n g eo ff r e q u e n -
cies (Table 4). There was also a rough negative correla-
tion between the percentage of Alu elements within a
given family that contained an HNF4a binding site and
A
Alu-derived
sites
134 66
HNF4D bound
HNF4D not bound
H4 sites in repeats
H4 sites not in repeats
1,320,513 total 
H4 sites Non Alu-
derived sites
994 2802
67,595
1,252,918
1,198,534 (~96%) in Alu repeats
54,384 (~4%) in non Alu repeats
B
Non-canonical
Alu-derived
DR2-derived
DR1-derived
H4sites:
Figure 2 The vast majority of HNF4a binding sites in the human genome are found in Alu repeats. A.N u m e r i c a lr e s u l t sf r o mP B M 3
described in Fig. 1 and in the text. B. Position weight matrices (PWMs) generated with Weblogo [76] of sequences bound by human HNF4a2i n
the PBM, categorized by the type of sequence. The DR1-derived PWM was from 994 sequences bound by HNF4a2, the DR2-derived PWM from
50 sequences and the Alu-derived sequences from 66 sequences. The non canonical PWM is from Bolotin et al. [42].
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Page 4 of 15the age of the family. The newest Alu family, AluY (~25
Mya), had the greatest percentage of HNF4a sites
(~91%); the second newest family, AluS (~30-55 Mya),
had the next highest percentage (~75%) and the oldest
family, Alu J (~55-65 Mya), had the lowest percentage
(~33%) (Table 3) [9]. This correlation held for the pre-
cursors to the Alu family as well. FAM (free Alu-like
monomer) sequences are Alu precursors that gave rise
to FRAM (free right Alu monomer) and FLAM (free left
Alu monomer) sequences that eventually joined to cre-
ate the modern dimeric Alu element [44]. The fre-
quency of the HNF4a binding sites in FAM (0.34%),
FRAM (11.84%) and FLAM_C (~33.77%) suggests that
the HNF4a sites may have first appeared in Alu-like
sequences in the FLAM family. Interestingly, not only
does AluJ have a similar frequency of HNF4a sites as
FLAM_C, but the HNF4a sites in AluJ are almost exclu-
sively in the left arm at position 31 (Figure 5). In con-
trast, the newer AluS family has significant secondary
sites at positions 62 and 200 while the newest Alu
family, AluY, has essentially the same number of
HNF4a sites at position 62 as at position 31, although
the number of sites at position 200 has remained rela-
tively low. All told, these results suggest that there has
been a gain of HNF4a binding sites in Alu elements
during the course of evolution. (See see additional file 2:
Table S3 for a complete list of Alu repeats with HNF4a
binding sites and their frequency in the human
genome.)
The human genome search also revealed ~54,000
occurrences of HNF4a sites in non Alu repeats (Figure
2A). The non Alu repeat families were numerically
dominated by repeats referred to as mammalian inter-
spersed repeats (MIRs), LINE2 elements (L2) and Tigger
(Table 5). However, while only ~1% of the MIRs and
L2s possess an HNF4a binding site, more than ~20% of
Tiggers do. In addition, more than 50% of the SVA
family of retrotransposons contain at least one HNF4a
site, although this is not surprising since these elements
contain a portion of an Alu element (see additional file
2: Table S4 for a complete list of frequencies of HNF4a
binding sites in non Alu repeats).
Frequency of HNF4a-Alu elements in promoters and
DNase hypersensitive sites
Others have shown that the region 5000 bp upstream
from the TSS (+1) contains on average 3.63 Alu ele-
ments [45]. We analyzed the same promoter region and
found that every human gene has on average 2.91
HNF4a-Alu elements, consistent with the overall high
proportion of Alu elements with an HNF4a site (Tables
3 and 4). To determine which Alu elements may be
accessible, and hence potentially play a role in transcrip-
tion regulation, we determined the number of HNF4a-
Alu elements that reside within DNase hypersensitive
regions using datasets from the ENCODE project
[46,47]. Genome-wide 46,129 HNF4a-Alu elements
(~6.2% of all HNF4a-Alu’s) are within DNase hypersen-
sitive regions across mutliple cell lines, with 5458 genes
containing one or more HNF4a-Alu/DNase sites in
their 5 kb promoter region. ~7000 HNF4a-Alu elements
are in DNase hypersensitive regions in HepG2 cells
alone (6212 from Rep Track 1 and 8127 from Rep
Track 2). While these findings may be an underestimate
due to the difficulty of sequencing through repetitive
elements, they nonetheless indicate that while the
majority of the ~750,000 HNF4a-Alu elements may not
be accessible in most cell types, a sizeable portion of
HNF4a-Alu elements are in regions of open chromatin
and hence may be transcriptionally active.
Age of Alu repeats in HNF4a target genes
In order to estimate the age of the various HNF4a-Alu
elements, we determined the presence of the Alu ele-
ments bound by HNF4a i nt h eH e p G 2C h I Pa s s a yi n
four sequenced primate genomes - marmoset, rhesus,
Table 1 Frequency of Alu-derived sequences bound by
HNF4a in Alu repeats and the human genome.
Sequence PBM score # in Alus # in hg18 %
TGACCTCGTGATC 0.62 101229 101259 99.97
TGAACCCGGGAGG 0.76 122111 122158 99.96
TGAACCTGGGAGG 0.73 126196 126368 99.86
TGACCTCATGATC 0.68 41447 41545 99.76
TGAACCCGGGAGA 0.61 5700 5716 99.72
TGGGGTTTCACCG 0.70 13385 13428 99.68
TGAACCCGGAAGG 0.69 4520 4535 99.67
TGACCTTGTGATC 0.64 40637 40786 99.63
TGAACTCGGGAGG 0.82 6783 6810 99.60
GCACTTTGGGAGG 0.84 469851 471728 99.60
TGAATCCGGGAGG 0.72 5765 5789 99.59
ACACTTTGGGAGG 0.69 38828 38993 99.58
GCACTTCGGGAGG 0.87 8683 8721 99.56
TGACCTCGCGATC 0.77 775 779 99.49
TGAACCCGAGAGG 0.62 4133 4156 99.45
GTACTTTGGGAGG 0.63 15294 15386 99.40
TGAACCCGGGGGG 9.02 1319 1328 99.32
TGACCTTGCGATC 0.73 411 414 99.28
TGACCTCGTGATT 0.63 2863 2888 99.13
GCACTCTGGGAGG 0.74 13202 13342 98.95
TGAGCCCGGGAGG 0.71 5450 5517 98.79
TGAGCCTGGGAGG 0.69 19616 19895 98.60
TGACCTCGTGACC 0.67 1070 1088 98.35
TGACCTCGTGACC 0.68 1070 1088 98.35
TGAACGCGGGAGG 0.72 642 653 98.32
TGACCTCAAATGA 0.63 8625 8779 98.25
PBM score is the average relative intensity of quadruplicate spots across four
arrays. Score >.612 indicates significant binding.
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GSTM4
IL32
ATPIF1
APOM
ABCC3
APOA4
FEM1A
SOCS2
CANX
TTR
PRODH2
IP6K2
pos control
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Figure 3 HNF4a binds Alu elements in vivo. A. HNF4a chromatin immunoprecipitation (ChIP) of HepG2 cells using 16 sets of PCR primers as
indicated. Shown is an ethidium-bromide-stained agarose gel of the qPCR products after ~40 cycles for graphical representation only. In, input
control of genomic DNA. IgG, control IP with normal rabbit IgG. H4, IP with HNF4a antibody raised in rabbit. Fold change, ratio of the H4 to IgG
signal determined by quantitative real time PCR (qPCR). Pos and neg control, regions of the CDKN1A promoter in which HNF4a was shown
previously to bind or not, respectively [71]; Alu generic, amplification with generic primers that recognize all Alu elements. Shown are the results
from one of two or more independent ChIP experiments performed in duplicate, except for APOM, GSTM4, PRLR and SOCS2 which are from one
ChIP experiment. The largest fold change values obtained for a given gene are indicated. B. Schematic diagram of promoters of HNF4a target
genes. Diamonds, position of HNF4a binding sites in Alu elements identified in this study; triangles, other HNF4a binding sites predicted by
PBM from Bolotin et al. [42]; vertical lines, position of the PCR primers used in the ChIP; arrows, start sites of transcription. See additional file 2:
Table S2 for sequences of all the PCR primers.
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Figure 4 HNF4a activates transcription from Alu elements. A. Reporter gene assay with the HNF4a-Alu elements from the indicated human
gene promoters fused to a minimal core promoter driving luciferase (pGL4.23). Shown is luciferase activity (relative light units, RLU) normalized
to b-gal activity (normalized RLU) from HEK 293T cells transiently transfected with 1 μg of reporter and different amounts of either empty vector
or human HNF4a2 expression vector (100, 200, 300 and 500 ng). Reporter constructs contain only the HNF4a-Alu element and immediately
adjacent sequence; they do not contain any additional known HNF4a binding sites. Data are the mean normalized RLU of triplicate samples
from one representative experiment from two or more that were performed. P-values of the HNF4a2 signal compared to the empty vector are
indicated. Fold induction by HNF4a2 compared to the empty vector is indicated. B. As in (A) but with two different reporter constructs
containing classical HNF4a response elements (RE-1 and RE-2). Shown is fold induction by 500 ng HNF4a2 compared to the parent construct
(pGL4.23). C. As in (A) but of the native human APOA4 promoter (-1343 to +247) fused to luciferase (pGL4.10) without (WT) or with mutations
(MUT) in either the HNF4a-Alu element (Alu) or a classical HNF4a site identified by a previous PBM analysis (HNF4a-PBM) (see Figure 3). Shown
is the fold induction by 500 ng HNF4a2 compared to the empty expression vector from one experiment performed in six replicates. A second
independent experiment performed in triplicate gave similar results. (B) and (C), sequence of the relevant HNF4a binding sites are given with
the spacer nucleotide in lower case and mutations in red.
Table 2 Number of Alu repeats with HNF4a binding sites
in the human genome (hg 18).
# of H4 sites in Alu # of Alus Total # of H4 sites
1 409,466 409,466
2 234,592 469,184
3 94,548 283,644
4 8762 35,048
5 232 1160
64 2 4
81 8
Total 747,605 1,198,534
Table 3 Alu families in human genome (hg18) with
HNF4a binding sites.
Alu # with H4 # in hg18 %
AluY 128,437 140,510 91.41
AluS 507,971 675,017 75.25
AluJ 102,628 307,445 33.38
FRAM 1005 8490 11.84
FLAM_C 7509 22,235 33.77
FLAM_A 39 16,050 0.24
FAM 16 4771 0.34
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Page 7 of 15orangutan and chimpanzee. The first mammalian pri-
mate originated ~60 million years ago (Mya). The mar-
moset monkey branched off from the human lineage
~35 Mya, the rhesus monkey ~25 Mya, the orangutan
~8 Mya and the chimpanzee ~5.5 Mya [48]. The results
show that all of the HNF4a-Alu elements examined are
older than humans (Figure 6), which is not surprising
since only ~ 5,000 or 0.5% of Alus are human-specific
[9]. Five of the ChIP’d HNF4a-Alu elements (in ABCC3,
ATPIF1, PRLR, TTR, SOD2) were common among all
the primate genomes, and thus fairly ancient (> 35 mil-
lion years old). An additional two elements (in APOA4
and SOCS2) also appear to be about 35 million years
old but may have been lost after chimps diverged from
the primate lineage. In contrast, five of the HNF4a-Alu
elements (in C A N X ,F E M 1 A ,G S T M 4 ,I P 6 K 2 ,P R O D H 2 )
appear to be somewhat newer (~25 million years old)
due to their presence in all primates except marmoset.
The two most recent elements (~8 million years old)
appear to be in the IL32 and APOM genes since they
are found only in orangutan, chimp and human. The
AluSq2 element in the IL32 gene, however, could be
older due to the fact that an entire region of the chro-
mosome, including the IL32 gene, is missing in rhesus
(Figure 7A). In the APOM gene, our ChIP results could
not distinguish whether the HNF4a site is in AluJr or
AluSg7; it is also curious that the AluSg7 element is
only partially missing in both rhesus and marmoset (Fig-
ure 7B). The AluSp element in the PRODH2 promoter,
in contrast, appears to have entered the primate lineage
after the divergence of the marmoset (35 Mya) but
before the divergence of the rhesus monkey (25 Mya),
consistent with the reported age of the AluS subfamily
(30-55 Mya) (Figure 7C). Assuming that the absence of
the HNF4a-Alu elements are not due simply to errors
in genome assembly and/or misclassification of Alu ele-
ments, these results suggest that HNF4a-Alu elements
could play a role in differential regulation of these genes
in different primate species.
Discussion
The functional relevance of repetitive DNA such as
Alu repeats in the human genome has been debated
ever since they were first discovered several decades
ago. In this study, we show that the nuclear receptor
HNF4a binds Alu-derived 13-mers in vitro as well as
Alu elements in the promoters of HNF4a target genes
in vivo. We show that HNF4a sites in Alu elements
can drive gene expression in luciferase assays and that
HNF4a binding sites are found in ~64% of all known
Alu repeats in the genome (~1.2 million HNF4a sites
in ~750,000 Alu elements). Additionally, we found that
while HNF4a sites are predominantly found in Alu
repeats, they are also found in other repeats such as
Table 4 Alu subfamilies in human genome (hg18) with
HNF4a binding sites.
Alu # with H4 # in hg18 %
AluYa5 3776 3851 98.05
AluYf5 173 178 97.19
AluY 112,814 118,382 95.30
AluYk4 1720 1831 93.94
AluSg 37,876 40,751 92.94
AluYb9 296 323 91.64
AluYb8 2526 2811 89.86
AluSc 30,426 33,886 89.79
AluSg7 7268 8207 88.56
AluSc8 19,011 21,491 88.46
AluSg4 6493 7347 88.38
AluYc3 492 566 86.93
AluSc5 5709 6766 84.38
AluYf4 1128 1353 83.37
AluSx3 23,542 28,952 81.31
AluSp 39,357 49,055 80.23
AluSx4 4499 5658 79.52
AluSq4 1086 1393 77.96
AluSq2 41,871 54,418 76.94
AluSq 16,472 21,472 76.71
AluYd8 167 221 75.57
0 100 200 300
H4 sites
An An
H4 site
31 62
Left arm Right arm
AluY
25 Mya
AluJ
~55 Mya
AluS
30-55 Mya
FLAM
~55-65 Mya
FRAM
~55-65 Mya
Figure 5 Distribution of HNF4a binding sites in Alu repeats.
Frequency histogram showing the position of HNF4a binding sites
in AluY, AluS, and AluJ families of SINEs as well as the precursors
FLAM and FRAM. The approximate age of the repeats is indicated.
The slight variation in peaks at positions 31, 62 and 200 are due to
small differences in the length of the Alu repeats.
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Page 8 of 15SVA elements, which contain a portion of Alu
repeat [49], and L2, MIR and Tigger families of
retrotransposons.
Functionality of HNF4a-Alu elements
Perhaps the most important question is how many of
the HNF4a-Alu elements are functional. Several recent
studies suggest that Alu elements may indeed play a
role in regulating gene expression: Alu elements are
enriched in regions with genes [50], particularly in
housekeeping and metabolism genes. However, they are
underrepresented in developmental genes [45], suggest-
ing that their presence in those genes may be detrimen-
tal. Binding sites for other NRs have also been found in
Alu repeats and several of those sites were found to
affect transcription [17,19-21]. To determine what types
of genes contain HNF4a-Alu elements, we performed a
Gene Ontology (GO) analysis of genes enriched with
HNF4a-Alu elements (> 8 per 5 kb promoter region)
and found RNA processing and transcription regulation
genes, as well as macromolecular catabolic processes
and complex assembly genes (see additional file 2:
Table S6 for a full list of significant GO categories and
relevant genes). RNA processing is not a category pre-
viously associated with classical HNF4a binding sites,
but Alu elements have been found to play a direct role
in alternative splicing [51].
In a detailed, genome-wide analysis of functional tar-
gets of HNF4a and binding sites, we recently found that
only 30% of genes down regulated in an HNF4a RNAi
experiment contained a potential classical HNF4a bind-
ing site [42]. While the other 70% could be indirect tar-
g e t s ,i ti sa l s op o s s i b l et h a ts o m eo ft h o s eg e n e sa r e
regulated by HNF4a-containing Alu elements, consis-
tent with our finding here that on average every gene in
the human genome contains ~2.91 HNF4a-Alu ele-
ments within 5000 bp upstream of the TSS. On an
Table 5 Non Alu repeat families in human genome (hg18) with HNF4a binding sites.
Sorted by number of HNF4a sites Sorted by prevalence of HNF4a sites
Transposon # with H4 # in hg18 % Transposon # with H4 # in hg18 %
MIRb 2333 223,605 1.04 SVA_C 215 281 76.51
L2a 2256 169,417 1.33 SVA_B 341 465 73.33
MIR 1586 173,924 0.91 SVA_D 932 1370 68.03
L2c 1455 139,570 1.04 SVA_A 132 259 50.97
Tigger2a 1186 3,316 35.77 (CCGGA)n 1 2 50.00
L2b 1050 96,999 1.08 HSATI 19 42 45.24
FRAM 1005 8,490 11.84 LTR22A 80 187 42.78
SVA_D 932 1,370 68.03 Tigger2a 1186 3316 35.77
L2 898 56,019 1.60 HERV-Fc2-int 1 3 33.33
MIR3 849 90,205 0.94 HERVE-int 80 250 32.00
MIRc 828 102,646 0.81 SVA_F 278 998 27.86
MSTA-int 730 3,104 23.52 Tigger2b_Pri 528 2000 26.40
L1PB1 698 13,202 5.29 PABL_A 126 511 24.66
MLT2A2 646 3,865 16.71 MSTB2-int 22 91 24.18
MER20 608 16,569 3.67 MSTA-int 730 3104 23.52
L1MC1 605 12,979 4.66 MER50 573 2527 22.68
MER50 573 2,527 22.68 LTR14B 78 357 21.85
Tigger2 546 2,735 19.96 MSTB-int 187 866 21.59
Tigger2b_Pri 528 2,000 26.40 MER8 408 1931 21.13
L1M5 482 63,783 0.76 MSTC-int 38 183 20.77
MLT1D 473 20,459 2.31 Tigger2 546 2735 19.96
>35Mya
>25Mya
>8Mya
Gene Alufamily Marmoset Rhesus Orangutan Chimp Human
ABCC3 AluSz +++++
ATPIF1 AluSx1 +++++
PRLR AluSc8 +++++
TTR AluJb +++++
APOA4 AluSx1 +++Ͳ +
SOCS2 AluSz +++Ͳ +
SOD2 AluSz +++++
CANX AluSx1 Ͳ ++++
FEM1A AluSq2 Ͳ ++++
GSTM4 AluSz Ͳ ++++
IP6K2 AluSg4 Ͳ ++++
PRODH2 AluSp Ͳ ++++
IL32 AluSq2 ͲͲ+++
APOM AluJr ͲͲ+++
Figure 6 Gene-specific HNF4a-Alu sequences in primate
genomes. Presence (+) and absence (-) of the HNF4a-Alu element
in the indicated HNF4a target genes as determined by ChIP analysis
(Figure 3) in all the sequenced primate genomes. Age in millions of
years ago (MYA) of the divergence from the primate lineage is
given on the right.
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Chip-Seq 
Rhesus 
Marmoset 
Orangutan 
Chimp 
Alu PBM 
B 
C 
APOM 
PRODH2 
RNA 
Repeats 
ChIP product 
Chip-Seq 
Rhesus 
Marmoset 
Orangutan 
Chimp 
RNA 
Repeats 
Alu PBM 
IL32 
Non Alu PBM 
AluSq2 
Non Alu PBM 
AluJr/Sg7 
ChIP product 
Rhesus 
Marmoset 
Orangutan 
Chimp 
Alu PBM 
RNA 
Repeats 
Non Alu PBM 
Chip-Seq 
AluSp 
Figure 7 Alu insertions in the promoters of IL32, APOM and PRODH2 genes. Screen shots from UCSC Genome Browser of human and
other indicated primate genomes in the region of the HNF4a-Alu element ChIP’d by HNF4a in the IL32 (A), APOM (B) and PRODH2 (C) genes.
Shown from top to bottom in each figure are non Alu HNF4a binding sites from Bolotin et al. [42] (Non Alu PBM); Alu sites from this study (Alu
PBM); mRNA from RefSeq track (RNA); HNF4a ChIP signal in HepG2 from the Custom Track by UC Davis (http://genome.ucsc.edu/ENCODE/)
(ChIP-Seq); DNA sequence conservation in four primate genomes (Rhesus, Marmoset, Orangutan, Chimp); PCR product amplified after ChIP in
Fig. 3 (ChIP product); repeats from Repeat Masker 3.2.7 with the relevant Alu sequence indicated (Repeats).
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Page 10 of 15individual gene basis, we found that even though the
HNF4a binding sites in Alu repeats are not high affinity
sites compared to the majority of classical HNF4a sites,
they are nonetheless capable of driving the expression of
a heterologous gene on their own. In the context of the
genome, however, the HNF4a-Alu elements are typically
present in conjunction with other TFBS in the promo-
ter, including other HNF4a binding sites, suggesting
that they may act in more of a modulatory capacity than
as the sole drivers of transcription, as we observed on
the APOA4 promoter. These results are similar to those
found for other NRs albeit on different binding sites
within the Alu elements [19-21].
The functionality of HNF4a-Alu elements, as with any
potential TFBS, will also depend on the state of the
local chromatin and the accessibility of the site to
HNF4a. While it has been reported that most Alu
repeats in the human genome contain CpG dinucleo-
tides that are methylated [52], potentially rendering
them nonfunctional, the Alu elements that are hypo-
methylated tend to be in promoter regions, suggesting
that they are accessible [52,53]. Indeed, our analysis
showed that there may be as many as ~46,000 HNF4a-
Alu elements in DNase hypersensitive regions genome-
wide, suggesting that they may be accessible for binding
and therefore may affect transcription.
Alu repeats as a sink for HNF4a protein?
In addition to affecting transcription directly, it is
tempting to speculate that the relatively large number of
HNF4a-Alu elements, especially in regions of open
chromatin, could act as a sink or reservoir for HNF4a
protein. We have estimated by semi-quantitative immu-
noblotting that there may be as many as 450,000 mole-
cules of HNF4a in the nucleus of an adult mouse
hepatocyte (unpublished observation); this estimate is
consistent with the fact that we originally had to purify
HNF4a only ~5,000 to 10,000-fold from adult rat liver
nuclei [54]. Assuming that human hepatocytes have
similar levels of HNF4a protein and keeping in mind
that HNF4a binds DNA only as a dimer [36], this sug-
gests that the presence of ~7000 to 46,000 HNF4a-Alu
elements in accessible regions of the genome would not
have a significant impact on the availability of ~225,000
HNF4a protein dimers in a normal adult hepatocyte
nucleus. However, conditions that significantly alter the
accessibility of the ~750,000 HNF4a-Alu elements gen-
ome-wide, or the amount of HNF4a protein, could in
theory result in a situation in which the stoichiometry
of HNF4a-Alu sites to HNF4a protein is indeed rele-
vant. For example, global loss of DNA methylation has
been associated with cancer progression and there is at
least one report in which certain Alu elements lose
methylation during tumor progression [55]. Likewise, a
decrease in the amount of functional HNF4a protein,
such as that found in heterozygous MODY1 patients
[31], activation of signaling pathways [56-61], DNA
damage via p53 [62,63], microRNAs [64], diet [35,65,66]
and diseases such as colitis and cancer [67,68] could tip
the balance between HNF4a protein and potential bind-
ing sites, rendering the notion of Alu elements as a sink
of HNF4a potentially relevant. The stoichiometry of
HNF4a protein to total HNF4a binding sites may also
differ in other tissues and developmental time points
[69], which could alter the relevance of HNF4a-Alu
elements.
Conclusion
The ~1.2 million HNF4a binding sites in ~750,000 Alu
elements in the human genome has the potential to
affect the expression of HNF4a target genes. Therefore,
it will be important to keep the HNF4a-Alu elements in
mind when investigating HNF4a function, especially
when using non primates as models for humans and
when investigating conditions, such as cancer, where
there may be genome-scale alterations in chromatin
accessibility. These results join the increasing number of
reports of NR and other TF binding sites in Alu or
other repeat elements [70] and support the notion that
repetitive DNA may be more than just “junk” DNA.
Methods
PBM design and analysis
A custom-designed 8x15k Alu PBM (PBM3) containing
8 grids, each of which consisted of ~15,000 spots of
DNA, was ordered from Agilent (Figure 1). An in silico
Alu library of ~200 DNA sequences was made by
extracting every unique 13-mer from every Alu element
consensus from the RepBase database (http://www.gir-
inst.org/repbase/). The human genome (hg18) was
searched with the Alu library and the 100 most frequent
sites were included on PBM3. The 13-mer Alu library
was further searched with the support vector machine
(SVM) model described in Bolotin et al [42]. (The SVM
is an algorithm trained on sequences bound by HNF4a
in the PBM; it predicts the binding HNF4a binding with
correlation R
2 = 0.76.) The top 100 scoring potential
HNF4a binding sites from the SVM search were
included on PBM3 for a total of 200-derived Alu
sequences. Another 704 sequences were included from
permutations of three adjacent positions in every combi-
nation of the DR1 consensus (5’-AGGTCAaAGGTCA-
3’) and 768 sequences from similar permutations of a
DR2 consensus (5’-AGGTCAaaAGGTCA-3’). Addition-
ally, 100 randomly generated 13-mers and 50 randomly
generated 14-mers were included as negative controls
for the DR1s and DR2s, respectively. Finally, an addi-
tional 2,061 unique sequences were generated from an
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unique DNA sequences, each of which was replicated 4
times on the PBM for a total of 15,208 DNA spots. The
linker and cap sequences were the same as those
described in Bolotin et al. [42]. (See additional file 2:
Table S5 for a list of all DNA sequences on PBM3 and
the corresponding HNF4a binding score.)
Crude nuclear extracts of COS-7 cells transfected with
human HNF4a2o rH N F 4 a8e x p r e s s i o nv e c t o r sw a s
applied to PBM3 (~400 ng HNF4a protein per grid)
and visualized and analyzed as described in Bolotin et
al. [42]. The primary antibody was a mouse monoclonal
that recognizes the C-terminal region of HNF4a (H1415
from R&D Systems); the secondary was NL-637 anti-
Mouse IgG (NL008 from R&D Systems). PBMs were
scanned using a GenePix Axon 4000B scanner (Molecu-
lar Devices, Sunnyvale, CA) at 543 nm (Cy3) dUTP and
633 nm (Cy5-conjugated secondary antibody). Since
there was no significant difference between the HNF4a2
and HNF4a8 isoforms, which differ by ~30 amino acids
in the N-terminal region but have identical DNA bind-
ing and dimerization/ligand binding domains, the aver-
age of the four grids (two with HNF4a2a n dt w ow i t h
HNF4a8) were used for the final PBM3 score. The
sequences with a score > 0.612 (i.e., 2 SD above the
mean of the random controls, p-value < .045) were con-
sidered to be HNF4a binders.
ChIP and RNAi Expression Profiling
HNF4a ChIP from HepG2 cells was performed as
described in [71]. Quantitative-PCR (qPCR) following
the ChIP was performed using BioRad IQ SYBR Green
Supermix. Each 23.5-ul reaction included 12.5 ul of
Supermix, 0.25 ul of 100 nmol of each primer, 0.5 ul of
template and 10 ul of ddH2O. The qPCR was performed
as follows: 95°C for 5 min (hot start), followed by 40
cycles 95°C for 30 sec (melt), 30 sec at the melting tem-
perature (Tm) for annealing and extension, followed by
a melt curve. The Tm was determined experimentally
for each pair of primers by using a temperature gradient
qPCR that was visualized on an ethidium bromide-
stained agarose gel to control for product size. All qPCR
was performed using BioRad iQ5 and myQ5 thermocy-
clers. (See additional file 2: Table S2 for a complete list
of PCR primers giving a positive ChIP signal.) Affyme-
trix expression profiling data for the HNF4a RNAi
knockdown in HepG2 cells were obtained from Bolotin
et al. [42].
Luciferase assay
Human embryonic kidney (HEK 293T) cells were plated
(0.25 × 10
6 cells) in 12-well plates. After 24 hr the cells
were transfected using Lipofectamine 2000 according to
the manufacturer’s protocol (Invitrogen), with different
amounts of empty vector (pcDNA3) or wild type
human HNF4a2i np c D N A 3 ,1μgo ft h el u c i f e r a s e
reporter and 200 ng of a CMV.bgal control. Cells were
harvested after 24 hr using Triton lysis buffer (1% Tri-
ton X-100, 25 mM Gly-Gly pH 7.8, 15 mM MgSO4, 4
m ME G T A ,1m MD T T ) .L u c i f e r a s ea n db-gal activity
were measured as described earlier [62]. Significant dif-
ferences in luciferase activity between cells transfected
with empty vector or human HNF4a2 were determined
by the Student’s t-test. APOM, PRODH2 and TTR luci-
ferase constructs were created by cloning PCR products
of the Alu elements in the respective promoters into
pGL4.23 (Promega): the APOM construct used SfiI
restriction sites and the PRODH2 and TTR constructs
used NheI and KpnI sites. The APOA4.Luc construct
w a sm a d eb yc l o n i n gaP C Rp r o d u c tf r o mt h eh u m a n
APOA4 promoter (-1343 to +247) into the pGL4.10 vec-
tor (Promega) at HindIII and NheI sites. Site-directed
mutations were introduced into the HNF4a binding
sites in the Alu and PBM elements using the Quik-
Change kit (Stratagene). Luciferase reporter constructs
with classical HNF4a response elements (RE-1 and RE-
2) were made by inserting the appropriate synthetic oli-
gonucleotides into pGL4.23. All constructs were
sequence verified. (See additional file 2:T a b l eS 2for
the sequence of the PCR primers and oligonucleotides
used in the constructions.)
Bioinformatic searches
Searches of human genome hg18 downloaded from
UCSC Genome Browser (http://genome.ucsc.edu) were
conducted using all of the sequences that HNF4a
b o u n di nP B M 3u s i n gS e q m a p[ 7 2 ] .A l ua n dn o nA l u
repeats with HNF4a sites were identified by comparing
the HNF4a genome-wide search results to the repeat
coordinates obtained from Repeat Masker Track version
3.2.7 in UCSC Genome Browser. The results were pro-
cessed using custom Perl scripts and an SQL database.
To determine accessibility of HNF4a-Alu sites, we used
BEDtools software package [73] to cross reference our
list of ~750,000 HNF4a-Alu elements (Table 2) with
DNase hypersensitivity tracks in the ENCODE Project
in UCSC Genome Bioinformatics, allowing for one
nucleotide or more of overlap. We used both the clus-
tered track that contains data from multiple human cell
lines (http://genome.ucsc.edu/cgi-bin/hgTrackUi?
hgsid=211217271&g=wgEncodeRegDnaseClustered) as
well as tracks for two different repetitions of HepG2
cells (http://genome.ucsc.edu/cgi-bin/hgTrackUi?
db=hg18&g=wgEncodeUwDnaseSeq). Gene Ontology
analysis of genes containing HNF4a-Alu elements was
d o n eu s i n gD A V I D[ 7 4 ] .W eu s e da sac u to f fe i g h t
HNF4a-Alu elements within 5 kb upstream of +1, two
SD above the average number of sites (2.91+4.22).
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Additional file 1: Overrepresentation of Alu-related HNF4a binding
motif (H4.141) in the human genome. Frequency profile of 217
HNF4a binding sites identified by gel shift assays and derived from the
literature in the human and mouse genomes.
Additional file 2: Supplementary Tables. Six tables with frequencies of
HNF4a binding sites in repetitive DNA, complete PBM and GO results,
and primers used in this study.
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